Last update : 07/07/2015 | Version : 2 | ID : 60158
General | |
Identification | |
Detailed name | Foetal Growth, Metabolic Syndrome and Insulin Resistance |
Sign or acronym | CASYMIR |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL |
General Aspects | |
Medical area |
Endocrinology and metabolism |
Health determinants |
Nutrition |
Keywords | Foetus, growth, anthropometry, metabolic status, hormonal status, nutritional status, birth |
Scientific investigator(s) (Contact) | |
Name of the director | Milanovic |
Surname | Ivana |
Name of the director | Levy-Marchal |
Surname | Claire |
Address | 75019 PARIS |
Phone | +33 (0)1 40 03 19 92 |
claire.levy-marchal@inserm.fr | |
Unit | U690 |
Organization | INSERM |
Collaborations | |
Funding | |
Funding status |
Mixed |
Details | PHRC National 2006 Pfizer international - Endocrie care |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | INSERM |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Cohort study |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Prospective. Inclusion cut-off date: 01/12/2008. Number of required subjects: [100-500]. |
Database objective | |
Main objective | To investigate early growth phases (foetal growth, birth weight and postnatal growth) in relation to elements of metabolic syndrome and insulin resistance. Secondary objective: to investigate growth and body composition, metabolic and hormonal profiles from birth until 4 years of age with regard to birth weight and foetal growth velocity. |
Inclusion criteria | Pregnancy with risk factor of low birth weight. |
Population type | |
Age |
Newborns (birth to 28 days) Infant (28 days to 2 years) Early childhood (2 to 5 years) |
Population covered |
General population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | Predominantly in 3 centres throughout Île-de-France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 09/2003 |
Date of last collection (YYYY or MM/YYYY) | 12/2012 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 580 femmes/women239 enfants/children |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Paraclinical data Biological data |
Clinical data (detail) |
Direct physical measures Medical registration |
Paraclinical data (detail) | Imaging |
Biological data (detail) | Metabolic profile and fasting hormone |
Presence of a biobank |
Yes |
Contents of biobank |
Serum Others |
Details of biobank content | Serum bank, placenta |
Health parameters studied |
Health event/morbidity Health event/mortality Health care consumption and services |
Care consumption (detail) |
Hospitalization Medical/paramedical consultation Medicines consumption |
Procedures | |
Data collection method | Clinical examinations: handwritten Biological analysis: direct input. |
Participant monitoring |
Yes |
Details on monitoring of participants | Every 4 years |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://tinyurl.com/Pubmed-CASYMIR |
Description | List of publications in Pubmed |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | To be decided if data may be used by academic teams. Data may not be used by industrial teams. |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05